Literature DB >> 21357420

G protein-coupled receptor kinase-2 is a novel regulator of collagen synthesis in adult human cardiac fibroblasts.

Karen M D'Souza1, Ricky Malhotra, Jennifer L Philip, Michelle L Staron, Tiju Theccanat, Valluvan Jeevanandam, Shahab A Akhter.   

Abstract

Cardiac fibroblasts (CF) make up 60-70% of the total cell number in the heart and play a critical role in regulating normal myocardial function and in adverse remodeling following myocardial infarction and the transition to heart failure. Recent studies have shown that increased intracellular cAMP can inhibit CF transformation and collagen synthesis in adult rat CF; however, mechanisms by which cAMP production is regulated in CF have not been elucidated. We investigated the potential role of G protein-coupled receptor kinase-2 (GRK2) in modulating collagen synthesis by adult human CF isolated from normal and failing left ventricles. Baseline collagen synthesis was elevated in failing CF and was not inhibited by β-agonist stimulation in contrast to normal controls. β-adrenergic receptor (β-AR) signaling was markedly uncoupled in the failing CF, and expression and activity of GRK2 were increased 3-fold. Overexpression of GRK2 in normal CF recapitulated a heart failure phenotype with minimal inhibition of collagen synthesis following β-agonist stimulation. In contrast, knockdown of GRK2 expression in normal CF enhanced cAMP production and led to greater β-agonist-mediated inhibition of basal and TGFβ-stimulated collagen synthesis versus control. Inhibition of GRK2 activity in failing CF by expression of the GRK2 inhibitor, GRK2ct, or siRNA-mediated knockdown restored β-agonist-stimulated inhibition of collagen synthesis and decreased collagen synthesis in response to TGFβ stimulation. GRK2 appears to play a significant role in regulating collagen synthesis in adult human CF, and increased activity of this kinase may be an important mechanism of maladaptive ventricular remodeling as mediated by cardiac fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21357420      PMCID: PMC3083230          DOI: 10.1074/jbc.M111.218263

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Seven-transmembrane-spanning receptors and heart function.

Authors:  Howard A Rockman; Walter J Koch; Robert J Lefkowitz
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

Review 2.  Structural and functional characterisation of cardiac fibroblasts.

Authors:  Patrizia Camelliti; Thomas K Borg; Peter Kohl
Journal:  Cardiovasc Res       Date:  2005-01-01       Impact factor: 10.787

Review 3.  The cardiomyopathy of overload: an unnatural growth response.

Authors:  A M Katz
Journal:  Eur Heart J       Date:  1995-12       Impact factor: 29.983

Review 4.  Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.

Authors:  M A Pfeffer; E Braunwald
Journal:  Circulation       Date:  1990-04       Impact factor: 29.690

5.  Chronic beta2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism.

Authors:  Neil A Turner; Karen E Porter; William H T Smith; Hazel L White; Stephen G Ball; Anthony J Balmforth
Journal:  Cardiovasc Res       Date:  2003-03       Impact factor: 10.787

6.  cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts.

Authors:  Xiaoqiu Liu; Rennolds S Ostrom; Paul A Insel
Journal:  Am J Physiol Cell Physiol       Date:  2004-01-07       Impact factor: 4.249

Review 7.  Myocardial remodeling after infarction: the role of myofibroblasts.

Authors:  Susanne W M van den Borne; Javier Diez; W Matthijs Blankesteijn; Johan Verjans; Leo Hofstra; Jagat Narula
Journal:  Nat Rev Cardiol       Date:  2009-12-01       Impact factor: 32.419

8.  Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor.

Authors:  W J Koch; H A Rockman; P Samama; R A Hamilton; R A Bond; C A Milano; R J Lefkowitz
Journal:  Science       Date:  1995-06-02       Impact factor: 47.728

9.  Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

Authors:  M Ungerer; M Böhm; J S Elce; E Erdmann; M J Lohse
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

10.  Structural basis of end-stage failure in ischemic cardiomyopathy in humans.

Authors:  C A Beltrami; N Finato; M Rocco; G A Feruglio; C Puricelli; E Cigola; F Quaini; E H Sonnenblick; G Olivetti; P Anversa
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

View more
  18 in total

1.  Adenosine 2A receptor promotes collagen production by human fibroblasts via pathways involving cyclic AMP and AKT but independent of Smad2/3.

Authors:  Miguel Perez-Aso; Patricia Fernandez; Aránzazu Mediero; Edwin S Chan; Bruce N Cronstein
Journal:  FASEB J       Date:  2013-11-07       Impact factor: 5.191

Review 2.  An updated review of mechanotransduction in skin disorders: transcriptional regulators, ion channels, and microRNAs.

Authors:  Jing Wang; Yifan Zhang; Ning Zhang; Chuandong Wang; Tanja Herrler; Qingfeng Li
Journal:  Cell Mol Life Sci       Date:  2015-02-15       Impact factor: 9.261

Review 3.  Cardiac Fibrosis: The Fibroblast Awakens.

Authors:  Joshua G Travers; Fadia A Kamal; Jeffrey Robbins; Katherine E Yutzey; Burns C Blaxall
Journal:  Circ Res       Date:  2016-03-18       Impact factor: 17.367

4.  β-Arrestins regulate human cardiac fibroblast transformation and collagen synthesis in adverse ventricular remodeling.

Authors:  Jinju Li; Jennifer L Philip; Xianyao Xu; Tiju Theccanat; M Abdur Razzaque; Shahab A Akhter
Journal:  J Mol Cell Cardiol       Date:  2014-08-15       Impact factor: 5.000

Review 5.  cAMP and Epac in the regulation of tissue fibrosis.

Authors:  Paul A Insel; Fiona Murray; Utako Yokoyama; Silvia Romano; Hongruo Yun; Loren Brown; Aaron Snead; David Lu; Nakon Aroonsakool
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

6.  GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension.

Authors:  Lin Piao; Yong-Hu Fang; Kishan S Parikh; John J Ryan; Karen M D'Souza; Tiju Theccanat; Peter T Toth; Jennifer Pogoriler; Jonathan Paul; Burns C Blaxall; Shahab A Akhter; Stephen L Archer
Journal:  Circulation       Date:  2012-11-02       Impact factor: 29.690

7.  SIRT3 Blocks Aging-Associated Tissue Fibrosis in Mice by Deacetylating and Activating Glycogen Synthase Kinase 3β.

Authors:  Nagalingam R Sundaresan; Samik Bindu; Vinodkumar B Pillai; Sadhana Samant; Yong Pan; Jing-Yi Huang; Madhu Gupta; Raghu S Nagalingam; Donald Wolfgeher; Eric Verdin; Mahesh P Gupta
Journal:  Mol Cell Biol       Date:  2015-12-14       Impact factor: 4.272

Review 8.  GRK2 in the heart: a GPCR kinase and beyond.

Authors:  Zheng Maggie Huang; Erhe Gao; J Kurt Chuprun; Walter J Koch
Journal:  Antioxid Redox Signal       Date:  2014-05-13       Impact factor: 8.401

9.  Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation.

Authors:  Corina Anastasaki; David H Gutmann
Journal:  Hum Mol Genet       Date:  2014-07-28       Impact factor: 6.150

10.  Developmental and tumoral vascularization is regulated by G protein-coupled receptor kinase 2.

Authors:  Verónica Rivas; Rita Carmona; Ramón Muñoz-Chápuli; Marta Mendiola; Laura Nogués; Clara Reglero; María Miguel-Martín; Ramón García-Escudero; Gerald W Dorn; David Hardisson; Federico Mayor; Petronila Penela
Journal:  J Clin Invest       Date:  2013-10-25       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.